I
Ignacio Ferreira-González
Researcher at Hebron University
Publications - 7
Citations - 187
Ignacio Ferreira-González is an academic researcher from Hebron University. The author has contributed to research in topics: Population & Ejection fraction. The author has an hindex of 3, co-authored 7 publications receiving 146 citations.
Papers
More filters
Journal ArticleDOI
Cardiac complications during pregnancy are better predicted with the modified WHO risk score
Antonia Pijuan-Domenech,Laura Galian,Maria Goya,M. Casellas,Carme Merced,Ignacio Ferreira-González,J.R. Marsal-Mora,Laura Dos-Subirà,M.T. Subirana-Domènech,V. Pedrosa,F. Baró-Marine,Susana Manrique,Jaume Casaldàliga-Ferrer,Pilar Tornos,Luis Cabero,David Garcia-Dorado +15 more
TL;DR: Improved prediction of CC risk during pregnancy can provide better preconception assessment in women with HD and mWHO was better at predicting CC than CARPREG;mWHO was also better at predicted CC than the specific CHD RS in the CHD subgroup.
Journal ArticleDOI
Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area.
Ignacio Ferreira-González,Josep Pinar-Sopena,Aida Ribera,Josep Ramon Marsal,Purificación Cascant,Teresa González-Alujas,Arturo Evangelista,Carlos Brotons,Irene Moral,Gaietà Permanyer-Miralda,David Garcia-Dorado,Pilar Tornos +11 more
TL;DR: The gradient in the association of cardiovascular risk factors with the severity of ASC suggests that they may be causally implied in the pathogenesis of the disease.
Journal ArticleDOI
Eplerenone in systemic right ventricle: double blind randomized clinical trial. The evedes study.
Laura Dos,Laura Dos,Sandra Pujadas,Montserrat Estruch,Assumpta Mas,Assumpta Mas,Ignacio Ferreira-González,Antonia Pijuan,Antonia Pijuan,Ricard Serra,Jordi Ordóñez-Llanos,Maite Subirana,Maite Subirana,Guillem Pons-Lladó,Josep Ramon Marsal,David Garcia-Dorado,Jaume Casaldáliga,Jaume Casaldáliga +17 more
TL;DR: Patients with SRV treated with eplerenone showed an improvement of an altered baseline CTB profile suggesting that reduction of myocardial fibrosis might be a therapeutic target in these patients.
Journal ArticleDOI
Association of renin–angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study
María José Soler,Aida Ribera,Josep Ramon Marsal,Ana Belen Mendez,Mireia Andres,María A Azancot,Gerard Oristrell,Leonardo Méndez-Boo,Jordana B. Cohen,José A. Barrabés,Ignacio Ferreira-González +10 more
Journal ArticleDOI
Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.
Enrique Galve,Gerard Oristrell,Gabriel Acosta,Aida Ribera-Solé,Àngel Moya-Mitjans,Ignacio Ferreira-González,Jordi Pérez-Rodon,David Garcia-Dorado +7 more
TL;DR: Repeated implantable cardioverter‐defibrillator (ICD) therapies cause myocardial damage and, thus, an increased risk of arrhythmias and mortality.